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Abstract 
BACKGROUND: In healthy persons, iron acquisition, trafficking and storage are strictly regulated processes due 
to the lack of a physiological pathway for the excretion of excess iron from the body. The liver, the duodenum and 
the bone marrow are involved in the regulation of iron metabolism.  
MATERIAL: Subject to the testing were 60 healthy volunteers who took part in clinical trials.  
METHODS: Case histories, physical check-up and demographic data including people’s heights and weights, 
laboratory studies and tests using medical equipment. 
RESULTS: None of the healthy persons were reported to have shown any deviation from the reference values for 
the serum markers of iron metabolism tested with the exception of hepcidin.  
CONCLUSION: In healthy persons, there was only a positive correlation between iron level and IBC, and 
feedback between hepcidin serum levels and transferrin saturation. 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Iron homeostasis depends on a complex 
mechanism on the principle of feedback between the 
needs of the human body for iron and intestinal 
absorption. There is no physiological mechanism for 
the excretion of excess iron. The hepcidin hormone, 
discovered in 2001, is now considered to be the key 
regulator of iron homeostasis. The impaired regulation 
of hepcidin is the reason for many of the iron 
homeostasis disorders [1], [2]. 
In healthy persons, iron absorption, transport 
and storage are strictly controlled processes due to 
the lack of a physiological pathway for the excretion of 
excess iron from the body. The liver, the duodenum 
and the bone marrow are involved in the control of 
iron metabolism. Healthy elderly people have approx. 
4 grams of iron in their bodies, about 3 grams of which 
are used to synthesize hemoglobin in the 
erythrocytes. When the erythrocytes get mature and 
die, their hemoglobin breaks down into its constituent 
parts-heme and globin. The heme-free iron is 
transferred from the transferrin to return to the heme 
synthesis cycle for erythropoiesis. These facts show 
that in a completely healthy adult, the body re-uses 
most of the available iron. Just 1 mg of iron is 
discharged from the body on a daily basis, mainly 
through the urine, faeces, enterocyte and epidermal 
desquamation in men, and through menstruation in 
women. Discharged iron is replaced by iron absorbed 
by the gastrointestinal tract through the food.  
 
 
Material and Methods 
 
Material 
Subject to the testing were 60 healthy 
volunteers involved in clinical trials None of them had 
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any medical history, physical, laboratory, serological 
(HIV, HBV, HCV and acute HAV infection) testing as 
well as ECG and ultrasound data for current or past 
liver and gallbladder diseases, anemia, diabetes 
mellitus, cardiovascular, renal and other significant 
diseases, pregnancy, medication and toxic substance 
intake, including absolute alcohol over 20g daily, and 
any other conditions that could affect the results. 
 
Methods 
1. Case histories, physical check-up and 
demographic data. 
2. Standard and specific disease-excluding 
laboratory blood and urine tests, immunological and 
virological studies. 
3. Laboratory test for evaluation of iron 
exchange: - Serum iron (men: 12.5 – 26 mmol/L; 
women: 10.5 - 23 mmol/L); - TIBS (44 - 66 mmol/L);     
- transferrin saturation (Fe ÷ TIBC × 100% –20-40%); 
- serum ferritin (men: 20 – 280 mg/L women: 10 – 140 
mg/L).  
Case histories, physical check-up and 
demographic data including: height, weight, BMI 
[(kg/m
2
 = body weight (kg)/Height (m
2
)], waist 
circumference. The changes in body mass were 
calculated using the WHO-based BMI classification 
(Table 1) [2], [4].  
Table 1: Assessment criteria for the changes in body mass 
according to the deviations from the WHO-based BMI [3], [4] 
Group* BMI (kg)/m2 
Underweight by BMI < 18.5 
Normal weight by BMI 18.5 – 24.9 
Overweight by BMI 25.0 – 29.9 
Obesity by BMI > 30.0 
- Class 1 30.0 – 34.9 
- Class 2 35.0 – 39.9 
- Class 3 > 40 
*Other classes – morbid obesity (BMI - 40-50) and super obesity (BMI > 50). 
 
 
 
Results 
 
In none of the healthy persons we observed 
any deviation in the serum markers of iron metabolism 
tested from the reference values with the exception of 
hepcidin. Twelve of the investigated persons (20%) 
showed hepcidin below the lower reference value.  
The mean values for the iron metabolism 
variables are given in Table 2.  
The serum iron levels in healthy persons 
showed a positive correlation with IBC (Pearson 
correlation, r = 0.303, p = 0.019). There was also a 
reciprocal correlation between the serum hepcidin 
levels and transferrin saturation (Pearson correlation r 
= - 0.675, p = 0.0001). 
Table 2: Serum iron metabolism variables in healthy people 
 Iron metabolism variable Healthy persons 
Serum iron (mmol/L Minimum 23.70 
 Maximum 812,00 
 Mean 18.30 
 Median 16.80 
 Standard deviation 4.66 
IBC (mmol/L)   Minimum 10.80 
 Maximum 30.2 
 Mean 56.80 
 Median 58.00 
 Standard deviation 6.14 
Ferritin (mg/l) Minimum 45.00 
 Maximum 73.5 
 Mean 147.32 
 Median 115.50 
 Standard deviation 91.59 
Transferrin saturation (%) Minimum 68.00 
 Maximum 397.00 
 Mean 31.15 
 Median 29.50 
 Standard deviation 5.31 
Hepcidin (ng/ml) Minimum 21.00 
 Maximum 40.01 
 Mean 99.14 
 Median 113.35 
 Standard deviation 32.94 
 
 
Relation of serum iron metabolism 
variables to sex, age and BMI  
In the group of healthy persons, we identified 
that the serum iron, IBC and ferritin values were 
considerably higher with men than those with women 
(Table 3) and also that there was no significant 
differences in transferrin saturation (p = 0.143) and 
hepidine (p = 0.228) between both sexes.  
Table 3: Serum iron metabolism variables (x± SD) relating to 
the sex of clinically healthy persons (Mann-Whitney) 
 
Variable 
Healthy persons 
 Men Women P= 
Serum iron (mmol/L Mean 18.84 17.77 
0.008 
 Standard deviation 3.09 5.83 
IBC (mmol/L)   Mean 58.76 54.84 0.034 
  Standard deviation 6.44 5.21 
Ferritin (mg/l) Mean 152.83 141.80 0.002 
  Standard deviation 72.14 108.62 
Transferrin saturation (%) Mean 32.27 30.03 0.143 
  Standard deviation 5.38 5.08 
Hepcidin (ng/ml) Mean 94.80 103.47 0.228 
  Standard deviation 34.26 31.54 
 
We identified no difference in the serum 
markers of iron metabolism of people under 45 years 
of age and those over 45 years old (Table 4). 
Furthermore, we could not prove any relation based 
on age.  
Table 4: Serum iron metabolism variables (x± SD) for clinically 
healthy persons aged under 45 and those aged over 45 (Mann-
Whitney) 
 
Variable 
Healthy persons 
 < 45 г > 45 г P 
Serum iron (mmol/L) Mean 18.86 18.03 
0.678 
 Standard deviation 5.18 4.42 
IBC (mmol/L)   Mean 56.82 56.80 
0.771 
 Standard deviation 6.13 6.22 
Ferritin (mg/l) Mean 127.10 157.43 
0.327 
 Standard deviation 66.05 101.25 
Transferrin saturation (%) Mean 29.95 31.75 
0.194 
 Standard deviation 5.64 5.10 
Hepcidin (ng/ml) Mean 108.72 94.35 
0.111 
 Standard deviation 26.24 35.15 
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The average BMI value for the group of 
healthy persons was 23.01 ± 2.54 (ranging between 
19.5 and 29.70), 50 (83%) of whom had normal body 
weight (BMI < 25) and the remaining 10 were 
overweight (BMI > 25 and < 30). No significant 
relation was identified between BMI and the serum 
iron metabolism variables (Table 5).  
Table 5: Serum iron metabolism variables (x± SD) for clinically 
healthy persons, obese and not obese (BMI > 30 and < 30) 
(Mann-Whitney) 
Variable BMI group Mean value 
Standard 
Deviation 
P = 
Serum iron (mmol/L)  
< 30 20.98 7.67 0.0001 
> 30 27.62 7.25 
IBC (mmol/L)  
< 30 64.50 11.45 0.0001 
> 30 74.92 11.92 
Ferritin (mg/l) 
< 30 194.68 192.83 0.0001 
 > 30 355.93 231.10 
Transferrin saturation (%) 
< 30 31.30 7.44 0.003 
> 30 35.38 7.24 
Hepcidin (ng/ml) 
< 30 87.59 39.94 0.002 
> 30 64.65 39.15 
 
 
 
Discussion 
 
In recent years, there has been an increased 
interest in the conditions and diseases accompanied 
by higher iron status and their evolution. Currently 
there are no sufficient comparative data available on 
the incidence and the characteristics of such disorders 
in people with chronic liver diseases compared to 
healthy people. For this purpose, we studied the 
serum iron metabolism in 60 healthy persons. 
Iron is essential for a number of key biological 
processes including erythrocyte production, DNA 
synthesis and cellular respiration [3], [5], [6]. The 
normal iron content in the body of an adult man is 35-
45 mg. iron per kilogram of body weight [3]. Most of 
the iron is combined with hemoglobin in the 
erythrocytes. The rest is distributed in the myoglobin 
in the muscles, in the tissue enzymes and the plasma 
transferin [3]. The liver parenchymal cells and the 
reticuloendothelial macrophages serve as a depot for 
storage of excess iron [3], [7]. In connection with its 
potential to take part in reactions as a transition metal, 
iron can be toxic in the cell [7], [1]. Iron-mediated 
generation of highly toxic Reactive Oxygen Species 
(ROS) plays a major role in the process leading to iron 
overload-related diseases [8]. 
Since there is no physiological pathway for 
the removal of excess iron from the body, iron 
acquisition, metabolism and storage must be strictly 
regulated [2], [6], [9]. A large number of new iron-
regulating molecules, including iron transporters and 
soluble mediators, have been identified in recent 
years. Divalent Metal Transporter-1 (DMT1, also 
known as Nramp2) is a multifunctional 
transmembrane protein [4], [10], [11] responsible for 
the passage of non-food iron through the apical 
surface of the absorbing enterocytes in the 
duodenum. Ferroportin (also known as MTP1, Ireg1) 
transports iron into the blood. As a portable metal, iron 
undergoes reduction and oxidation reactions during 
this cell intake [7], [11]. Iron circulates in the plasma 
by binding to glyco protein, transferrin (Tf). The iron 
delivering Tf is absorbed by the cell to form 
compounds with transferrin receptor 1, TrfR [3], [7], 
[10]. 
Regulation of the iron metabolism involves 
many organs – the duodenum, the liver, the bone 
marrow. The identification of hepcidin-peptide 
emphasizes the importance of the liver in iron 
homeostasis. Hepcidin is an antimicrobial peptide that 
is isolated from human urine and blood [3], [6]. It is 
synthesized in the liver hepatocytes. Hepcidin 
synthesis in the liver is sensitive to iron levels-it 
increases in the presence of excessive iron and 
decreases in cases of iron deficiency [12], [13], [14].  
Interestingly, the synthesis of hepcidin is also 
regulated by inflammatory signals and by the 
inflammatory cytokines IL-1 and IL-6 [1], [15]. The role 
of the Kupffer cells in the regulation of hepcidin levels 
in inflammation is disputable. 
Hepcidin plays a major role in iron metabolism 
by inhibiting intestinal iron metabolism and iron 
release by the macrophages [7], by binding to 
ferroportin and inducing cellular penetration and 
degradation [15].  
In conclusion, a better understanding of the 
molecular mechanisms that regulate the iron 
homeostasis can help develop therapeutic strategies 
and diagnostic methods for the detection of liver 
diseases in their early stages before they could turn 
into chronic diseases and cause irreversible liver 
damage.  
In healthy persons there is only a positive 
correlation between iron level and IBC, and feedback 
between hepcidin serum levels and transferrin 
saturation. 
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